Financials from Rhelion Life Sciences Corp.'s company filings · Latest period: 2026-Q3 (ended )
Revenue
$1.26M
+8.2% vs a year earlier
Net loss
$1.38M
Operating cash flow
-$800.8K
Cash
$9.88M
Red Light Holland Corp. specializes in the production and sale of magic truffles for the recreational market in the Netherlands. The company has a strong liquidity position, indicated by a current ratio of 4.56 and low debt levels (Debt/Equity of 0.11), which suggests financial stability. However, it faces significant profitability challenges, with negative EBITDA and net margins, indicating ongoing operational losses. The low stock price relative to its market cap raises concerns about investor confidence despite its niche market presence.
Loading financial metrics...
Revenue fell 22.4% year-over-year from $5.4M to $4.2M. The decline has persisted for multiple quarters.
Company posted a loss of $-4.8M over the last year, representing 114.5% of revenue.
Operating cash flow has been negative for 3 consecutive quarters, burning $2.5M over the last year.
Fortress balance sheet: cash covers total debt 5.7×, providing significant financial flexibility.
Excellent liquidity with current ratio of 4.6x ensures operational stability.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q3 (December 31, 2025)